Nextech is a global, cancer therapeutics-focused venture capital firm headquartered in Zurich, Switzerland. We focus almost exclusively on oncology therapeutics, and on helping to drive value creation for our portfolio companies. We invest in the most promising drug discovery companies with the potential to create multiple medicines. Our portfolio is focused throughout the US and Europe with investments from company inceptions to crossover rounds.
View Top Employees from Nextech InvestWebsite | http://www.nextechinvest.com |
Revenue | $2 million |
Employees | 24 (19 on RocketReach) |
Founded | 1998 |
Address | 18 Bahnhofstrasse, Zürich, Zurich 8001, CH |
Phone | +41 44 366 66 11 |
Fax | +41 44 366 66 10 |
Technologies |
JavaScript,
HTML,
PHP
+8 more
(view full list)
|
Industry | Venture Capital and Private Equity Principals, Business Services General, Business Services |
Web Rank | 11 Million |
Keywords | Cit Lung Cancer Market, Dr. David Greenberg, Phd Mit, Schroeder Thilo, Nextechinvest, Nextech Invest Ltd. Harvard Med |
SIC | SIC Code 679 Companies, SIC Code 67 Companies |
NAICS | NAICS Code 523 Companies, NAICS Code 52 Companies, NAICS Code 5239 Companies |
Looking for a particular Nextech Invest employee's phone or email?
The Nextech Invest annual revenue was $2 million in 2024.
Rocco Sgobbo is the Partner of Nextech Invest.
19 people are employed at Nextech Invest.
Nextech Invest is based in Zürich, Zurich.
The NAICS codes for Nextech Invest are [523, 52, 5239].
The SIC codes for Nextech Invest are [679, 67].